当前位置: 首页 > 期刊 > 《中国医学创新》 > 202013
编号:13479579
220例绝经后女性乳腺癌临床病理特征及治疗分析(5)
http://www.100md.com 2020年5月5日 《中国医学创新》 202013
     [18] Maaren M,Munck L,Jobsen J,et al.Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer:a population-based study on 10-year overall,relative,and distant metastasis-free survival in 3071 patients[J].2016,160(3):1-11.

    [19]邵志敏.乳腺癌保乳手术的进展与评述[J].肿瘤防治研究,2018,45(5):269-273.

    [20]郭斌,王圣应.早期乳腺癌的外科治疗进展[J].蚌埠医学院学报,2019,6(4):1-15.

    [21]中国抗癌协会乳腺癌专业委员会.乳腺肿瘤整形与乳房重建专家共识(2018年版)[J].中国癌症杂志,2018,28(6):439-480.

    [22] Doré M,Cutuli B,Cellier P,et al.Hypofractionated irradiation in elderly patients with beast cancer after breast conserving surgery and mastectomy:analysis of 205 cases[J].Radiation Oncology,2015,10(1):161.

    [23] Gradishar W J,Anderson B O,Balassanian R,et al.Breast Cancer,Version 4.2017,NCCN Clinical Practice Guidelines in Oncology[J].Journal of the National Comprehensive Cancer Network Jnccn,2018,16(3):310-320.

    [24] Freedman R A.Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer[J].Breast Diseases:A Year Book Quarterly,2015,26(2):166-168.

    (收稿日期:2019-11-12) (本文編辑:程旭然), http://www.100md.com(张振华 苏合朋 党相国 李湘奇)
上一页1 2 3 4 5